GlassScriptPhysician profile
Edward H Maa
NPI 1053426643
$165,027.84
in general payments reported to CMS, 2019-2025
65 companies · $59K in 2025
The $59K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,299 · 2020: $11K · 2021: $12K · 2022: $9,803 · 2023: $23K · 2024: $45K · 2025: $59K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Consulting Fee: $43K · Food and Beverage: $17K · Travel and Lodging: $11K · Education: $17.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $55,384.92 |
| Consulting Fee | $43,293.47 |
| Food and Beverage | $17,084.71 |
| Travel and Lodging | $10,693.76 |
| Education | $17.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuropace, INC. | $55,979.32 | 2019-2025 | |
| Ucb, INC. | $20,070.01 | 2019-2025 | Fintepla, Briviact, Nayzilam |
| Sk Life Science, INC. | $18,343.13 | 2020-2025 | Xcopri |
| Livanova USA, INC. | $17,422.56 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Jazz Pharmaceuticals INC. | $15,888.36 | 2022-2025 | |
| Neurelis, INC. | $13,350.39 | 2020-2025 | Valtoco |
| Greenwich Biosciences, INC. | $9,787.57 | 2019-2021 | |
| Abbvie INC. | $2,662.09 | 2022-2025 | |
| Pfizer INC. | $991.49 | 2023-2025 | |
| Catalyst Pharmaceuticals, INC. | $791.48 | 2023-2025 | Fycompa, Firdapse |
| Celgene Corporation | $633.23 | 2022-2025 | Zeposia |
| Eisai INC. | $625.56 | 2019-2023 | |
| Emd Serono, INC. | $569.11 | 2022-2025 | Mavenclad |
| Novartis Pharmaceuticals Corporation | $532.75 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $519.79 | 2022-2025 | Ingrezza, Ongentys |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $519.55 | 2022 | |
| Merz Pharmaceuticals, LLC | $421.42 | 2022-2025 | Xeomin, Ampyra, Inbrija |
| Teva Pharmaceuticals USA, INC. | $368.36 | 2022-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Genzyme Corporation | $305.04 | 2022-2025 | |
| Tanabe Pharma America, INC. | $286.28 | 2023-2025 | Radicava |
| Tg Therapeutics, INC. | $255.47 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $243.33 | 2022-2025 | Ultomiris |
| Acadia Pharmaceuticals INC | $239.39 | 2022-2025 | Nuplazid |
| Argenx US, INC. | $226.88 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Medtronic, INC. | $222.17 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $209.10 | 2023-2025 | Acthar |
| Amneal Pharmaceuticals LLC | $199.99 | 2022-2025 | Crexont, Rytary |
| Genentech USA, INC. | $199.25 | 2022-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Sunovion Pharmaceuticals INC. | $198.59 | 2022 | |
| Lilly USA, LLC | $197.36 | 2022-2023 | Emgality, Reyvow |
| Amgen INC. | $178.25 | 2022-2025 | Uplizna, Aimovig |
| Allergan, INC. | $172.69 | 2022 | |
| Boston Scientific Corporation | $169.33 | 2022-2025 | Vercise, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $153.19 | 2022-2025 | Infinity |
| Biogen, INC. | $136.05 | 2022 | |
| Upsher-Smith Laboratories LLC | $129.68 | 2022 | |
| Axsome Therapeutics, INC. | $129.16 | 2023-2025 | Sunosi, Symbravo |
| Lundbeck LLC | $128.80 | 2022-2025 | Vyepti |
| Grt US Holding, INC. | $128.71 | 2022 | |
| Octapharma USA, INC. | $128.45 | 2022-2023 | Panzyga |
| Csl Behring | $89.94 | 2022-2024 | Hizentra |
| Astrazeneca Pharmaceuticals LP | $82.89 | 2024-2025 | Wainua |
| Banner Life Sciences, LLC | $81.37 | 2024 | |
| Mdd US Operations, LLC | $79.65 | 2022-2025 | Gocovri, Gocovri |
| Immedica Pharma US, INC. | $78.10 | 2022 | |
| Collegium Pharmaceutical, INC. | $77.36 | 2022 | |
| Acorda Therapeutics, INC | $73.17 | 2022-2023 | Inbrija |
| Kyowa Kirin, INC. | $65.98 | 2023-2024 | Nourianz |
| Cadwell Industries, INC | $65.81 | 2025 | |
| Scilex Pharmaceuticals INC. | $64.92 | 2023-2024 | Ztlido |
| Ani Pharmaceuticals, INC. | $63.95 | 2022-2025 | Purified Cortrophin Gel |
| Impel Pharmaceuticals INC. | $58.56 | 2023 | Trudhesa |
| Alnylam Pharmaceuticals INC. | $54.86 | 2022-2025 | Amvuttra |
| Grifols USA, LLC | $50.17 | 2022-2024 | Gamunex-C |
| Springworks Therapeutics, INC. | $49.31 | 2025 | Gomekli |
| Sumitomo Pharma America, INC. | $40.85 | 2023-2024 | Aptiom |
| Otsuka America Pharmaceutical, INC. | $34.13 | 2023-2024 | Nuedexta |
| Vanda Pharmaceuticals INC. | $31.90 | 2025 | Ponvory |
| Avanir Pharmaceuticals, INC. | $28.72 | 2022 | |
| Supernus Pharmaceuticals, INC. | $28.16 | 2022 | |
| Avion Pharmaceuticals | $25.51 | 2023 | Dhivy |
| Harmony Biosciences LLC | $24.66 | 2025 | |
| Janssen Pharmaceuticals, INC | $24.38 | 2022 | |
| Almatica Pharma LLC | $21.38 | 2022 | |
| Amylyx Pharmaceuticals, INC. | $18.78 | 2023 | Relyvrio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Maa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.